Effect of Metformin on the Clinical Outcomes of Stroke in Patients with Diabetes: a Systematic Review and Meta-analysis

Overview

Journal BMJ Open

Date 2025 Jan 17

PMID 39819905

Authors

Jianyi Liu

Zhihua Huang

Fuqun Luo

Yizhi Guo

Yandeng Li

Jun Wen

Jianming Zhu

Affiliations

Soon will be listed here.

Abstract

Objectives: Stroke is a major cause of death and disability globally, especially among diabetic patients. In this study, we aim to scrutinise the effects of metformin on the clinical outcomes of stroke in diabetic patients.

Design: This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.

Data Sources: PubMed, Embase and Web of Science databases were searched between their inception and 5 December 2023.

Eligibility Criteria For Selecting Studies: Studies investigating the effect of metformin on the clinical outcomes of stroke in patients with diabetes were included.

Data Extraction And Synthesis: The effect of metformin on the clinical outcomes of stroke in patients with diabetes was identified using combined ORs and 95% CIs.

Results: A total of 11 studies involving 18 525 participants were included in this review. Pooled analysis has demonstrated that prestroke metformin use could reduce the probability of poor course after stroke by 34% in diabetes mellitus (DM) patients (OR=0.66, 95% CI: 0.61 to 0.72) and reduce the probability of death by 43% (OR=0.57, 95% CI: 0.51 to 0.64).

Conclusions: Prestroke metformin use is beneficial for the improvement of clinical outcomes in patients who had a stroke with DM, although the potential bias should be carefully considered.

Prospero Registration Number: CRD42024496056.

References

Desilles J, Meseguer E, Labreuche J, Lapergue B, Sirimarco G, Gonzalez-Valcarcel J . Diabetes mellitus, admission glucose, and outcomes after stroke thrombolysis: a registry and systematic review. Stroke. 2013; 44(7):1915-23. DOI: 10.1161/STROKEAHA.111.000813. View

Amato S, Liu X, Zheng B, Cantley L, Rakic P, Man H . AMP-activated protein kinase regulates neuronal polarization by interfering with PI 3-kinase localization. Science. 2011; 332(6026):247-51. PMC: 3325765. DOI: 10.1126/science.1201678. View

Akiyama N, Yamashiro T, Ninomiya I, Uemura M, Hattori Y, Ihara M . Neuroprotective effects of oral metformin before stroke on cerebral small-vessel disease. J Neurol Sci. 2023; 456:122812. DOI: 10.1016/j.jns.2023.122812. View

Kamouchi M, Matsuki T, Hata J, Kuwashiro T, Ago T, Sambongi Y . Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry. Stroke. 2011; 42(10):2788-94. DOI: 10.1161/STROKEAHA.111.617415. View

Tu W, Zeng Q, Wang K, Wang Y, Sun B, Zeng X . Prestroke Metformin Use on the 1-Year Prognosis of Intracerebral Hemorrhage Patients with Type 2 Diabetes. Oxid Med Cell Longev. 2021; 2021:2027359. PMC: 8457962. DOI: 10.1155/2021/2027359. View

Zhao M, Li X, Chen D, Hao F, Tao S, Yu H . Neuro-Protective Role of Metformin in Patients with Acute Stroke and Type 2 Diabetes Mellitus via AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Pathway and Oxidative Stress. Med Sci Monit. 2019; 25:2186-2194. PMC: 6442495. DOI: 10.12659/MSM.911250. View

Eriksson M, Carlberg B, Eliasson M . The disparity in long-term survival after a first stroke in patients with and without diabetes persists: the Northern Sweden MONICA study. Cerebrovasc Dis. 2012; 34(2):153-60. DOI: 10.1159/000339763. View

Kuwashiro T, Kamouchi M, Ago T, Hata J, Sugimori H, Kitazono T . The factors associated with a functional outcome after ischemic stroke in diabetic patients: the Fukuoka Stroke Registry. J Neurol Sci. 2011; 313(1-2):110-4. DOI: 10.1016/j.jns.2011.09.012. View

Deng T, Zheng Y, Hou W, Yuan Y, Shen Z, Wu X . Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction. Neurochem Res. 2016; 41(10):2719-2727. DOI: 10.1007/s11064-016-1988-8. View

10.

Horsdal H, Mehnert F, Rungby J, Johnsen S . Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study. J Stroke Cerebrovasc Dis. 2011; 21(8):717-25. DOI: 10.1016/j.jstrokecerebrovasdis.2011.03.007. View

11.

Jiang S, Li T, Ji T, Yi W, Yang Z, Wang S . AMPK: Potential Therapeutic Target for Ischemic Stroke. Theranostics. 2018; 8(16):4535-4551. PMC: 6134933. DOI: 10.7150/thno.25674. View

12.

Murala S, Nagarajan E, Bollu P . Infectious Causes of Stroke. J Stroke Cerebrovasc Dis. 2022; 31(4):106274. DOI: 10.1016/j.jstrokecerebrovasdis.2021.106274. View

13.

Curro C, Fiume G, Cotroneo M, Russo G, Casella C, DellAera C . Ischemic stroke and reperfusion therapies in diabetic patients. Neurol Sci. 2022; 43(7):4335-4348. DOI: 10.1007/s10072-022-05935-x. View

14.

Wang L, Li G, Hao Y, Hao M, Xiong Y . Intravenous thrombolysis for mild stroke: NIHSS 3-5 Versus NIHSS 0-2. J Stroke Cerebrovasc Dis. 2023; 32(5):107070. DOI: 10.1016/j.jstrokecerebrovasdis.2023.107070. View

15.

Benjanuwattra J, Apaijai N, Chunchai T, Kerdphoo S, Jaiwongkam T, Arunsak B . Metformin preferentially provides neuroprotection following cardiac ischemia/reperfusion in non-diabetic rats. Biochim Biophys Acta Mol Basis Dis. 2020; 1866(10):165893. DOI: 10.1016/j.bbadis.2020.165893. View

16.

Favilla C, Mullen M, Ali M, Higgins P, Kasner S . Sulfonylurea use before stroke does not influence outcome. Stroke. 2011; 42(3):710-5. DOI: 10.1161/STROKEAHA.110.599274. View

17.

Guzik A, Bushnell C . Stroke Epidemiology and Risk Factor Management. Continuum (Minneap Minn). 2017; 23(1, Cerebrovascular Disease):15-39. DOI: 10.1212/CON.0000000000000416. View

18.

Li J, Benashski S, Venna V, McCullough L . Effects of metformin in experimental stroke. Stroke. 2010; 41(11):2645-52. PMC: 2994809. DOI: 10.1161/STROKEAHA.110.589697. View

19.

Wu S, Wang C, Jia Q, Liu G, Hoff K, Wang X . HbA1c is associated with increased all-cause mortality in the first year after acute ischemic stroke. Neurol Res. 2014; 36(5):444-52. DOI: 10.1179/1743132814Y.0000000355. View

20.

Paridari P, Jabermoradi S, Gholamzadeh R, Vazifekhah S, Vazirizadeh-Mahabadi M, Dizaji S . Can metformin use reduce the risk of stroke in diabetic patients? A systematic review and meta-analysis. Diabetes Metab Syndr. 2023; 17(2):102721. DOI: 10.1016/j.dsx.2023.102721. View